Apogem Capital’s Madison Square Garden MSGS Stock Holding History

Apogem Capital’s Portfolio MSGS Stock Details MSGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,654	Closed	-$636K	–	79
2022 Q3	$636K	Buy	4,654 +654	+16%	+$102K	0.63%	52
2022 Q2	$604K	Hold	4,000	–	–	0.55%	60
2022 Q1	$717K	Buy	4,000 +905	+29%	+$154K	0.49%	67
2021 Q4	$538K	Buy	+3,095	New	+$562K	0.35%	90
2021 Q1	–	Sell	-2,388	Closed	-$440K	–	198
2020 Q4	$440K	Buy	+2,388	New	+$393K	0.29%	102

Other funds holding MSGS

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $31.7B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Apogem Capital's MSGS Position: Q4 2022 in Review

Apogem Capital sold out of Madison Square Garden (MSGS) in Q4 2022, closing a stake of 4,654 shares — an estimated $636K sold.

Apogem Capital first reported a position in MSGS in Q4 2020 and held it in 5 quarters. The position peaked at $717K in Q1 2022. 264 funds tracked by Wall St. Rank hold MSGS as of Q4 2022.

Apogem Capital reported no remaining Madison Square Garden position as of Q4 2022 after selling out during the quarter.
Apogem Capital sold 4,654 Madison Square Garden shares in Q4 2022, an estimated $636K.
Apogem Capital first reported a position in Madison Square Garden in Q4 2020 and held it in 5 quarters.
Apogem Capital's Madison Square Garden position peaked at $717K in Q1 2022.
264 funds tracked by Wall St. Rank held Madison Square Garden as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.